The SMA gene therapy candidate OAV101 IT, a version of Zolgensma, can be safely given to previously treated patients, per new trial data.
SMA News Today is providing live coverage of the MDA Clinical & Scientific Conference taking place March 16-19 in Dallas. Stay tuned to this page for all the latest news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback